Specifically, COL17A1 levels in breast carcinomas and lung adenocarcinomas are similar, while the COL17A1 levels are highest in normal breast tissue and lowest in normal lung tissue (Fig. 5g). This evidence concerns the gene COL17A1 and lung adenocarcinoma.